Related Experiment Video
Updated: Jul 19, 2026
10:17
The Tail Suspension Test
Published on: January 29, 2012
Changes in plasma monoamine metabolites during acute lithium intoxication
Reiji Yoshimura1, Yasuhisa Yamada, Nobuhisa Ueda
1Department of Psychiatry, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, Japan.
Human Psychopharmacology
|October 31, 2002
Summary
This study examined acute lithium intoxication, finding that toxic lithium levels temporarily increased serotonin and noradrenaline function, as indicated by elevated MHPG and 5-HIAA plasma levels. Dopamine function remained unaffected.
Area of Science:
- Neuroscience
- Clinical Pharmacology
- Toxicology
Background:
- Lithium is a widely used mood stabilizer.
- Acute lithium intoxication can lead to serious adverse effects.
- Understanding the neurochemical changes during intoxication is crucial for patient management.
Purpose of the Study:
- To investigate the longitudinal changes in key neurotransmitter metabolites during acute lithium intoxication.
- To determine the specific neurochemical pathways affected by toxic lithium levels.
Main Methods:
- A case study of acute lithium intoxication.
- Longitudinal measurement of plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG), 5-hydroxyindoleacetic acid (5-HIAA), and homovanillic acid (HVA).
Main Results:
- Plasma MHPG and 5-HIAA levels were significantly increased during the intoxication period.
- Plasma HVA levels did not show a significant increase.
- These findings suggest a transient enhancement of noradrenaline and serotonin function.
Conclusions:
- Acute lithium intoxication may lead to enhanced serotonin and noradrenaline activity.
- Dopamine function appears to be unaffected by toxic lithium concentrations in this case.
- These neurochemical alterations provide insights into the pathophysiology of lithium toxicity.
Related Concept Videos
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:24Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
01:24Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...